Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer

Immunotherapy has transformed lung cancer treatment, significantly improving patients’ treatment prospects. But gaps remain. In non-small cell lung cancer, 27 to 46% of patients respond to initial checkpoint inhibitor therapy, and of those who do, the majority develop resistance within four years, according to a study in Cancers 2024. What if a natural polymer produced… The post Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer appeared first on Drug Discovery and Development.

Continue reading →